IRTC - iRhythm Technologies, Inc.
| Previous Close | 68.41 |
| Open | 68.39 |
| Bid | 68.90 x 900 |
| Ask | 76.82 x 800 |
| Day's Range | 66.64 - 69.16 |
| 52 Week Range | 55.18 - 98.37 |
| Volume | 514,267 |
| Avg. Volume | 522,927 |
| Market Cap | 1.686B |
| Beta (3Y Monthly) | 1.70 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.02 |
| Earnings Date | Apr 30, 2019 - May 6, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 96.86 |
-
Business Wire • 9 days ago
Glancy Prongay & Murray LLP Announces Investigation on Behalf of iRhythm Technologies, Inc. Investors (IRTC)
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC) investors concerning the Company and its officers’ possible violations of federal securities laws. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. Between March 13 and March 27, 2019, a series of reports alleged that the Company’s revenue base relied on “an exceedingly generous, but increasingly fragile, reimbursement regime.” These reports also alleged that the Company engaged in deceptive accounting practices.
-
ACCESSWIRE • 10 days ago
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of iRhythm Technologies, Inc. (IRTC)
NEW YORK, NY / ACCESSWIRE / April 10, 2019 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc.("iRhythm" or the "Company") ...
-
Business Wire • 11 days ago
Robbins Arroyo LLP Is Investigating the Officers and Directors of iRhythm Technologies, Inc. (IRTC) on Behalf of Shareholders
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of iRhythm Technologies, Inc. breached their fiduciary duties to shareholders by failing to maintain effective internal controls over financial reporting.
-
Business Wire • 12 days ago
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of iRhythm Technologies, Inc. Investors
Law Offices of Howard G. Smith announces an investigation on behalf of iRhythm Technologies, Inc. investors concerning the Company and its officers’ possible violations of federal securities laws.
-
Business Wire • 15 days ago
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of iRhythm Technologies, Inc. (“iRhythm” or “the Company”) (NASDAQ: IRTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
-
Business Wire • 17 days ago
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of iRhythm Technologies, Inc. (“iRhythm” or “the Company”) (NASDAQ: IRTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
-
PR Newswire • 18 days ago
Lifshitz & Miller LLP Announces Investigation of Amyris, Inc., iRhythm Technologies, Inc., Orion Group Holdings, Inc., Osmotica Pharmaceuticals plc, Quantenna Communications, Inc., WABCO Holdings, Inc. and Zafgen, Inc.
NEW YORK , April 2, 2019 /PRNewswire/ -- Amyris, Inc. (AMRS) Lifshitz & Miller announces investigation into possible securities laws violations in connection with Amyris' announcement that it was unable ...
-
ACCESSWIRE • 18 days ago
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 2, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of iRhythm Technologies, Inc. ("iRhythm" or "the Company") (NASDAQ: IRTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
-
GlobeNewswire • 19 days ago
Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. (IRTC) on Behalf of Stockholders and Encourages IRTC Investors to Contact the Firm
NEW YORK, April 01, 2019 -- Bragar Eagel & Squire, P.C. is investigating potential claims against iRhythm Technologies, Inc. (NASDAQ: IRTC). Our investigation concerns.
-
GlobeNewswire • 19 days ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of iRhythm Technologies, Inc.
NEW YORK, April 01, 2019 -- Levi & Korsinsky announces it has commenced an investigation of iRhythm Technologies, Inc. (NASDAQGS: IRTC) concerning possible violations of.
-
ACCESSWIRE • 19 days ago
INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of iRhythm Technologies, Inc. (IRTC)
NEW YORK, NY / ACCESSWIRE / April 1, 2019 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc.("iRhythm" or the "Company") ...
-
GlobeNewswire • 23 days ago
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of iRhythm Technologies, Inc. (“iRhythm” or “the Company”) (NASDAQ: IRTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Analysts also questioned if the Company’s statements on the total addressable market for its products may have been misleading.
-
Business Wire • 23 days ago
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against iRhythm Technologies, Inc. – IRTC
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of iRhythm Technologies, Inc. resulting from allegations that iRhythm may have issued materially misleading business information to the investing public.
-
PR Newswire • 24 days ago
Hagens Berman Alerts iRhythm Technologies (IRTC) Investors of Investigation of Possible Disclosure Violations
SAN FRANCISCO , March 27, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in iRhythm Technologies, Inc. (NASDAQ: IRTC) of the firm's investigation of possible violations of the ...
-
GuruFocus.com • last month
Irhythm Technologies Inc (IRTC) President and CEO Kevin M King Sold $5.3 million of Shares
President and CEO of Irhythm Technologies Inc (NASDAQ:IRTC) Kevin M King sold 60,000 shares of IRTC on 03/15/2019 at an average price of $88.76 a share.
-
Investor's Business Daily • last month
Apple Study Bodes Well For Makers Of Wearable Heart Monitors
A Stanford Medicine report that analyzed the usefulness of Apple's smartwatch in detecting irregular heart rhythms bodes well for makers of dedicated heart monitoring devices, analysts say.
-
Barrons.com • last month
iRhythm Stock Could Get a Lift from Apple Heart Study Results, Analyst Says
The high-profile study shines a positive light on the cardiac monitoring market. That’s good news for iRhythm Technologies stock.
-
Benzinga • last month
Kerrisdale Short iRhythm Technologies, Claims Company Is Abusing Reimbursement Process
Irhythm Technologies Inc (NASDAQ: IRTC) shares traded lower on Wednesday after Kerrisdale Capital said it's short the stock and expects iRhythm’s revenue growth to slow dramatically in coming quarters. Kerrisdale’s bearish thesis is based on iRhythm’s Zio single-lead heart rate monitor, which accounts for nearly all of the company’s $150 million in revenue. “A closer look at the circumstances surrounding the reimbursement treatment of the Zio Patch reveals that at the core of iRhythm’s revenue base is an exceedingly generous, but increasingly fragile, reimbursement regime,” Kerrisdale claims in its report.
-
GuruFocus.com • 2 months ago
iRhythm Technologies Inc (IRTC) Files 10-K for the Fiscal Year Ended on December 31, 2018
Warning! GuruFocus has detected 3 Warning Signs with MATX. For the last quarter iRhythm Technologies Inc reported a revenue of $43.2 million, compared with the revenue of $28.18 million during the same period a year ago. The iRhythm Technologies Inc had an operating margin of -29.61%, compared with the operating margin of -27.68% a year before.
-
GlobeNewswire • 2 months ago
The Future Is Now; Med Tech That’s Changing Lives
Investorideas.com, a leading investor news resource covering medical technology and healthcare stocks releases a snapshot looking at the rapid advancements happening in the med tech sector and how many of these “far off” projects are now on the verge of reality. BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, recently announced that the Company successfully conducted the first patient cases using PURE EP™ System, its FDA approved proprietary signal acquisition and processing technology. The first commercial use of the System was completed at the Texas Cardiac Arrhythmia Institute (“TCAI”) in Austin, TX.
-
Zacks • 2 months ago
IRHYTHM TECH (IRTC) Reports Q4 Loss, Tops Revenue Estimates
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of -4.35% and 6.03%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
-
GlobeNewswire • 2 months ago
iRhythm Technologies Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Full Year 2019 Financial Outlook
SAN FRANCISCO, Feb. 12, 2019 -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today.
-
Zacks • 2 months ago
Will IRHYTHM TECH (IRTC) Report Negative Earnings Next Week? What You Should Know
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
